WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST)

Historical Holders from Q1 2014 to Q4 2025

Symbol
WST on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
71,941,794
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
68,656,889
Holdings value
$17,956,700,750
% of all portfolios
0.01%
Number of holders
745
Number of buys
374
Number of sells
328
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13% $2,545,899,009 9,704,948 The Vanguard Group 30 Sep 2025
BlackRock, Inc. 8.4% $1,311,168,054 6,066,852 BlackRock, Inc. 31 Mar 2025
As of 30 Sep 2025 WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 745 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68,656,889 shares of 71,941,794 outstanding shares and own 95% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) own 63% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 13% $2,545,899,009 9,704,948 +4.2%
BlackRock, Inc. 9% $1,693,566,022 6,455,861 -2.3%
STATE STREET CORP 4.5% $841,531,293 3,207,911 -2%
Bank of New York Mellon Corp 4% $761,992,358 2,904,709 -9.4%
Artisan Partners Limited Partnership 3.9% $726,895,444 2,770,920 +22%
BROWN ADVISORY INC 3.5% $655,329,708 2,498,082 -17%
GEODE CAPITAL MANAGEMENT, LLC 2.6% $485,197,258 1,857,124 +1.3%
MORGAN STANLEY 2.1% $387,889,624 1,478,629 -0.44%
VAN ECK ASSOCIATES CORP 2% $373,789,000 1,424,879 -4.1%
APG Asset Management N.V. 2% $315,621,614 1,413,698 -15%
Durable Capital Partners LP 1.6% $307,603,698 1,172,583 +13%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1.4% $272,323,326 1,038,094 -1.3%
GENERATION INVESTMENT MANAGEMENT LLP 1.4% $256,037,753 976,014 -16%
FRANKLIN RESOURCES INC 1.3% $253,392,682 965,931 -13%
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.2% $232,223,960 885,236 -15%
Invesco Ltd. 1.2% $231,187,494 881,285 -8.2%
Findlay Park Partners LLP 1.1% $210,416,467 802,106 -1.8%
NORTHERN TRUST CORP 1% $195,407,256 744,891 -0.67%
CITADEL ADVISORS LLC 1% $190,854,781 727,537 +465%
T. Rowe Price Investment Management, Inc. 0.97% $184,003,000 701,415 +50%
Point72 Asset Management, L.P. 0.92% $172,942,016 659,253 +94%
ProShare Advisors LLC 0.85% $160,708,605 612,620 -17%
TD Asset Management Inc 0.84% $159,059,073 606,332 +26%
ROYAL BANK OF CANADA 0.78% $146,846,000 559,775 +2.9%
AQR CAPITAL MANAGEMENT LLC 0.76% $142,949,255 545,879 +420%

Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 14,137 $3,890,196 +$92,986 $275.14 5
2025 Q3 68,656,889 $17,956,700,750 -$185,069,789 $262.33 745
2025 Q2 70,038,330 $15,270,649,646 +$210,523,894 $218.80 724
2025 Q1 68,953,513 $15,407,189,292 -$318,348,909 $223.88 703
2024 Q4 69,774,879 $22,842,891,962 +$206,715,816 $327.56 741
2024 Q3 68,502,767 $20,491,378,046 +$105,304,444 $300.16 721
2024 Q2 68,264,555 $22,427,067,892 -$85,436,872 $329.39 765
2024 Q1 68,476,899 $27,013,149,916 -$61,599,634 $395.71 773
2023 Q4 68,654,469 $24,095,915,369 -$40,197,518 $352.12 776
2023 Q3 68,617,905 $25,750,554,481 +$188,033,862 $375.21 753
2023 Q2 68,109,208 $25,959,372,992 -$536,833,981 $382.47 727
2023 Q1 69,530,466 $24,023,693,976 +$337,155,239 $346.47 685
2022 Q4 69,130,558 $16,274,465,898 +$84,036,083 $235.35 627
2022 Q3 68,591,681 $16,905,826,463 -$426,987,902 $246.08 621
2022 Q2 68,252,580 $20,598,288,583 -$313,220,081 $302.37 645
2022 Q1 68,987,302 $28,230,153,122 +$12,831,022 $410.71 703
2021 Q4 68,897,668 $32,124,610,400 +$628,245,813 $469.01 719
2021 Q3 67,352,622 $28,445,255,423 -$757,416,674 $424.54 660
2021 Q2 69,185,010 $24,703,501,155 +$168,106,325 $359.10 632
2021 Q1 68,655,696 $19,249,105,816 -$1,483,079 $281.78 581
2020 Q4 68,772,292 $19,420,583,256 +$181,864,375 $283.31 582
2020 Q3 68,011,060 $18,672,970,021 -$206,990,921 $274.90 565
2020 Q2 68,729,649 $15,713,367,193 +$430,300,021 $227.17 516
2020 Q1 67,095,723 $10,218,503,618 -$57,849,907 $152.25 458
2019 Q4 67,516,262 $10,147,693,254 +$89,380,655 $150.33 438
2019 Q3 67,073,748 $9,511,691,556 -$48,072,443 $141.82 399
2019 Q2 67,459,734 $8,439,980,479 +$21,201,788 $125.15 366
2019 Q1 67,782,706 $7,469,804,358 -$147,754,418 $110.20 369
2018 Q4 69,304,554 $6,793,717,291 +$30,353,474 $98.03 345
2018 Q3 68,762,507 $8,489,518,317 +$105,177,114 $123.47 347
2018 Q2 69,014,206 $6,851,742,817 -$115,598,904 $99.29 316
2018 Q1 70,245,901 $6,201,570,320 +$38,472,059 $88.29 321
2017 Q4 69,798,001 $6,886,660,375 -$49,215,782 $98.67 333
2017 Q3 69,787,442 $6,716,535,721 +$236,119,441 $96.26 299
2017 Q2 67,340,267 $6,364,939,261 +$134,188,764 $94.52 309
2017 Q1 66,678,304 $5,442,811,783 +$392,806,753 $81.61 289
2016 Q4 67,087,906 $5,690,874,395 +$81,927,181 $84.83 284
2016 Q3 66,232,350 $4,932,244,183 +$58,975,958 $74.50 273
2016 Q2 66,741,578 $5,067,062,425 -$136,060,448 $75.88 284
2016 Q1 68,346,963 $4,740,630,733 +$68,000,266 $69.32 246
2015 Q4 67,388,697 $4,057,814,648 -$10,518,430 $60.22 245
2015 Q3 67,592,322 $3,658,107,595 +$15,378,346 $54.12 247
2015 Q2 67,515,045 $3,921,152,772 +$8,866,404 $58.08 217
2015 Q1 67,356,211 $4,051,881,972 +$106,839,580 $60.21 212
2014 Q4 65,784,192 $3,501,807,017 -$17,047,109 $53.24 224
2014 Q3 66,150,209 $2,960,879,964 +$86,227,818 $44.76 212
2014 Q2 64,480,946 $2,719,765,820 +$33,968,152 $42.18 221
2014 Q1 63,620,215 $2,802,477,916 +$26,493,263 $44.05 223